441 related articles for article (PubMed ID: 17059971)
21. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
Sorensen SV; Frick KD; Wade A; Simko R; Burge R
Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
[TBL] [Abstract][Full Text] [Related]
23. The costs and benefits of enhanced depression care to employers.
Wang PS; Patrick A; Avorn J; Azocar F; Ludman E; McCulloch J; Simon G; Kessler R
Arch Gen Psychiatry; 2006 Dec; 63(12):1345-53. PubMed ID: 17146009
[TBL] [Abstract][Full Text] [Related]
24. A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA.
Palmer AJ; Valentine WJ; Chen R; Mehin N; Gabriel S; Bregman B; Rodby RA
Nephrol Dial Transplant; 2008 Apr; 23(4):1216-23. PubMed ID: 18359872
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness of usual general practitioner care with or without antidepressant medication for patients with minor or mild-major depression.
Bosmans JE; Hermens ML; de Bruijne MC; van Hout HP; Terluin B; Bouter LM; Stalman WA; van Tulder MW
J Affect Disord; 2008 Nov; 111(1):106-12. PubMed ID: 18342952
[TBL] [Abstract][Full Text] [Related]
26. Diabetes mellitus: implications, costs and issues.
Lowe H
West Indian Med J; 2001 Mar 1-4; 50 Suppl 1():13-4. PubMed ID: 15973806
[No Abstract] [Full Text] [Related]
27. [Pharmacoeconomy of diabetes mellitus--trends in the Czech Republic].
Horák P
Vnitr Lek; 2009 Apr; 55(4):331-40. PubMed ID: 19449745
[TBL] [Abstract][Full Text] [Related]
28. The impact of prevention on reducing the burden of cardiovascular disease.
Kahn R; Robertson RM; Smith R; Eddy D
Circulation; 2008 Jul; 118(5):576-85. PubMed ID: 18606915
[TBL] [Abstract][Full Text] [Related]
29. Simulation based cost-benefit analysis of a telemedical system for closed-loop insulin pump therapy of diabetes.
Bott OJ; Hoffmann I; Bergmann J; Kosche P; von Ahn C; Mattfeld DC; Schnell O; Pretschner DP
Stud Health Technol Inform; 2006; 124():435-40. PubMed ID: 17108558
[TBL] [Abstract][Full Text] [Related]
30. The cost-utility of a care coordination/home telehealth programme for veterans with diabetes.
Barnett TE; Chumbler NR; Vogel WB; Beyth RJ; Ryan P; Figueroa S
J Telemed Telecare; 2007; 13(6):318-21. PubMed ID: 17785029
[TBL] [Abstract][Full Text] [Related]
31. Cost of diabetes and its complications in Thailand: a complete picture of economic burden.
Chatterjee S; Riewpaiboon A; Piyauthakit P; Riewpaiboon W; Boupaijit K; Panpuwong N; Archavanuntagul V
Health Soc Care Community; 2011 May; 19(3):289-98. PubMed ID: 21276105
[TBL] [Abstract][Full Text] [Related]
32. Global cost-effectiveness of cataract surgery.
Lansingh VC; Carter MJ; Martens M
Ophthalmology; 2007 Sep; 114(9):1670-8. PubMed ID: 17383730
[TBL] [Abstract][Full Text] [Related]
33. Innovative approaches to reduce diabetes costs.
Reese AB
N C Med J; 2011; 72(5):409-12. PubMed ID: 22416528
[TBL] [Abstract][Full Text] [Related]
34. The economic imperative to conquer diabetes.
Fradkin J; Rodgers GP
Diabetes Care; 2008 Mar; 31(3):624-5. PubMed ID: 18308686
[No Abstract] [Full Text] [Related]
35. A systems approach to diabetes care.
Mazze RS
Diabetes Care; 1994 Jun; 17 Suppl 1():5-11. PubMed ID: 8088224
[TBL] [Abstract][Full Text] [Related]
36. Cost of care of schizophrenia: a study of Indian out-patient attenders.
Grover S; Avasthi A; Chakrabarti S; Bhansali A; Kulhara P
Acta Psychiatr Scand; 2005 Jul; 112(1):54-63. PubMed ID: 15952946
[TBL] [Abstract][Full Text] [Related]
37. The economic burden of diabetes.
Dall TM; Zhang Y; Chen YJ; Quick WW; Yang WG; Fogli J
Health Aff (Millwood); 2010 Feb; 29(2):297-303. PubMed ID: 20075080
[TBL] [Abstract][Full Text] [Related]
38. [The cost per year of life gained: trends and internal contradictions].
Smulders YM; Thijs A
Ned Tijdschr Geneeskd; 2006 Nov; 150(45):2467-70. PubMed ID: 17137090
[TBL] [Abstract][Full Text] [Related]
39. [Economic analysis and public health. Why does one need economic evaluation applied to diabetes? What methods does one choose: cost effectiveness, cost utility, cost benefit? Are such studies useful in terms of public health?].
Triomphe A
Diabete Metab; 1993 Dec; 19(5 Suppl):473-6. PubMed ID: 8206181
[TBL] [Abstract][Full Text] [Related]
40. Cost effectiveness of community-based physical activity interventions.
Roux L; Pratt M; Tengs TO; Yore MM; Yanagawa TL; Van Den Bos J; Rutt C; Brownson RC; Powell KE; Heath G; Kohl HW; Teutsch S; Cawley J; Lee IM; West L; Buchner DM
Am J Prev Med; 2008 Dec; 35(6):578-88. PubMed ID: 19000846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
